CIK: 0001910264
申报总市值
US$9.2亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | 股票-其他 | 39.29% | +7.77% | — | |
| 2 | ZBIO | Zenas Biopharma INC | 股票-其他 | 16.66% | -15.14% | — | |
| 3 | SPRY | Ars Pharmaceuticals INC | 股票-其他 | 11.67% | -3.10% | — | |
| 4 | CRSP | CRISPR Therapeutics AG | 股票-医疗保健 | 9.88% | -4.55% | — | |
| 5 | DSGN | Design Therapeutics INC | 股票-其他 | 7.04% | -1.08% | — | |
| 6 | MLYS | Mineralys Therapeutics INC | 股票-其他 | 4.90% | -3.40% | — | |
| 7 | ALMS | Alumis INC | 股票-其他 | 4.20% | +2.01% | — | |
| 8 | NKTX | Nkarta INC | 股票-其他 | 3.02% | -0.10% | — | |
| 9 | ORKA | Oruka Therapeutics INC | 股票-其他 | 1.84% | +0.46% | — | |
| 10 | ✓ | Engene Holdings INC | 股票-其他 | 0.99% | -0.40% | +49.55% | |
| 11 | KALAEUR | Kala Bio INC | 股票-其他 | 0.51% | — | — |